Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Stürzebecher

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Investigative Dermatology|July 22, 2006
Increased expression of Wnt5a in psoriatic plaquesJoachim Reischl, Susanne Schwenke, Johanna M Beekman, et al.
Current Medical Research and Opinion|September 13, 2011
Systematic review of tapentadol in chronic severe painRob Riemsma, Carol Forbes, Julie Harker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosisBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
Journal of Neuroimmunology|June 21, 2008
Biological response genes after single dose administration of interferon beta-1b to healthy male volunteersJan Hilpert, Johanna M Beekman, Susanne Schwenke, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 8, 2005
Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patientsCarmen Infante-Duarte, Alexandra Weber, Jörn Krätzschmar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Investigative Dermatology|July 22, 2006
Increased expression of Wnt5a in psoriatic plaquesJoachim Reischl, Susanne Schwenke, Johanna M Beekman, et al.
Current Medical Research and Opinion|September 13, 2011
Systematic review of tapentadol in chronic severe painRob Riemsma, Carol Forbes, Julie Harker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosisBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
Journal of Neuroimmunology|June 21, 2008
Biological response genes after single dose administration of interferon beta-1b to healthy male volunteersJan Hilpert, Johanna M Beekman, Susanne Schwenke, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 8, 2005
Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patientsCarmen Infante-Duarte, Alexandra Weber, Jörn Krätzschmar, et al.
Pageof 1